Junfei Zhao
Columbia University in the City of New York
H-index: 31
North America-United States
Top articles of Junfei Zhao
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Aberrant β-catenin signaling from the bone marrow niche leads to transformation of IDH1/2-mutant hematopoietic stem cells and compromises response to IDH1/2 … | Cancer Research | Paraskevi Vgenopoulou Luis Flores Ioanna Mosialou Junfei Zhao X Shawn Liu | 2024/3/22 |
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth | Cell Metabolism | Aida Rashidi Leah K Billingham Andrew Zolp Tzu-yi Chia Caylee Silvers | 2024/1/2 |
B-cells drive response to PD-1 blockade in glioblastoma upon neutralization of TGFβ-mediated immunosuppression | Research Square | David Hou Brandyn Castro Mark Dapash Andrew Zolp Joshua Katz | 2023/1/9 |
2013–MESENCHYMAL STROMAL CELL MITOCHONDRIAL TRANSFER FUELS MDS TO AML TRANSFORMATION | Experimental Hematology | Rossella Labella Abdullah Ali Ioanna Mosialou Jessica De Angelis Paraskevi Vgenopoulou | 2023/1/1 |
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma | Nature communications | Peng Zhang Aida Rashidi Junfei Zhao Caylee Silvers Hanxiang Wang | 2023/3/23 |
Mechanisms of insertions at a DNA double-strand break | Molecular Cell | Jaewon Min Junfei Zhao Jennifer Zagelbaum Jina Lee Sho Takahashi | 2023/7/20 |
Author Correction: Multiscale reorganization of the genome following DNA damage facilitates chromosome translocations via nuclear actin polymerization | Nature Structural & Molecular Biology | Jennifer Zagelbaum Allana Schooley Junfei Zhao Benjamin R Schrank Elsa Callen | 2023 |
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade | Nature communications | Crismita Dmello Junfei Zhao Li Chen Andrew Gould Brandyn Castro | 2023/3/22 |
Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma | JNCI: Journal of the National Cancer Institute | Sara Viragova Luis Aparicio Pierangela Palmerini Junfei Zhao Luis E Valencia Salazar | 2023/7/1 |
Inverse agonists of RAR/RXR signaling as lineage-specific anti-tumor agents against human Adenoid Cystic Carcinoma | JNCI: Journal of the National Cancer Institute | Sara Viragova Luis Aparicio Pierangela Palmerini Junfei Zhao Luis E Valencia Salazar | 2023 |
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy | Annals of Oncology | Kieron White Kate Connor Maxime Meylan A Bougoüin Manuela Salvucci | 2023/3/1 |
Multiscale reorganization of the genome following DNA damage facilitates chromosome translocations via nuclear actin polymerization | Nature Structural & Molecular Biology | Jennifer Zagelbaum Allana Schooley Junfei Zhao Benjamin R Schrank Elsa Callen | 2023/1 |
ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion | Nature communications | Demis Menolfi Brian J Lee Hanwen Zhang Wenxia Jiang Nicole E Bowen | 2023/6/19 |
Pervasiveness of HLA allele-specific expression loss across tumor types | Genome Medicine | Ioan Filip Anqi Wang Oleksandr Kravets Rose Orenbuch Junfei Zhao | 2023/2/9 |
Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence | Clinical Cancer Research | Margaret Johnson April Bell Kristen L Lauing Erik Ladomersky Lijie Zhai | 2023/12/1 |
TMIC-15. AGE-RELATED MARKERS FOR SENESCENCE INCREASE IN THE OLDER ADULT EXTRATUMORAL MOUSE BRAIN DUE TO GLIOBLASTOMA | Neuro-Oncology | April Bell Margaret Johnson Erik Ladomersky Miri Kim Junfei Zhao | 2022/11/1 |
Abstract B36: Nano-engineering of immunosuppressive myeloid cells for immunostimulation in glioblastoma | Cancer Immunology Research | Peng Zhang Aida Rashidi Junfei Zhao Brandyn Castro Abby Ellingwood | 2022/12/1 |
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma | Nature Cancer | Víctor A Arrieta Andrew X Chen J Robert Kane Seong Jae Kang Cynthia Kassab | 2022/3 |
830 Targeting B cell suppression to improve the efficacy of immunotherapies in brain cancer | David Hou Brandyn Castro Andrew Zolp Mark Dapash Victor Arrieta | 2022/11/1 | |
TMIC-10. IDENTIFICATION, VALIDATION AND BIOLOGICAL CHARACTERIZATION OF NOVEL GLIOBLASTOMA TUMOUR MICROENVIRONMENT SUBTYPES: IMPLICATIONS FOR PRECISION IMMUNOTHERAPY | Neuro-Oncology | Kieron White Kate Connor Maxime Meylan Antoine Bougoüin Manuela Salvucci | 2022/11/1 |
